Breast Cancer Clinical Advisory Board

Arnold Baskies, MD, FACS

Dr. Baskies is a specialist in surgical oncology and general surgery, affiliated with Virtua Health Systems.  He is former Chairman of the National Board of Directors of the American Cancer Society and current Chair of the society’s Global Cancer Control Advisory Council.  He is a member of the Global Breast ...

Read More

G. Thomas Budd, MD, FACP

Dr. Budd is a specialist in breast cancer and the principal investigator of the Cleveland Clinic and Anixa partnered Phase 1 trial of the Breast Cancer Vaccine.  He is Professor of Medicine in the Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic Cancer Center, and Professor in the ...

Read More

Brian Leyland-Jones, MBBS, MD, Ph.D., FACP, FRCPC

Dr. Leyland-Jones is a pre-eminent clinical trialist in oncology and the recipient of numerous awards.  He is the Chief Medical Officer of AIM-HI Accelerator Fund, OTraces, and the N OF 1 Mission.  In addition, he is a Scientific Advisory Board Member of the National Foundation for Cancer Research and NED ...

Read More

Hope Rugo, MD, FASCO

Dr. Rugo is a leader and specialist in breast cancer research and recipient of numerous awards.  She is Professor, Department of Medicine (Hematology/Oncology), and Director, Breast Oncology and Clinical Trials Education, at the UCSF Helen Diller Family Comprehensive Cancer Center.  She is Co-chair of the Triple Negative Working Group, a member ...

Read More

Stephen Schoenberger, PH.D.

Dr. Schoenberger is a translational immunologist working in the area of precision cancer immunotherapy.  He is a professor in the Center for Cancer Immunotherapy at the La Jolla institute for Immunology and Adjunct Professor of Medicine in the Division of Hematology and Oncology at the UC San Diego Moores Cancer ...

Read More

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Read More...

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

Read More...

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

Read More...